Outlook Therapeutics Inc. (OTLK)
NASDAQ · Healthcare
Outlook Therapeutics Inc. Long Term Debt 2015–2025
Outlook Therapeutics Inc. annual/quarterly long term debt history from 2015 to 2019. Long term debt refers to financial obligations that are due more than one year in the future.
- Outlook Therapeutics Inc. long term debt for the quarter ending September 30, 2019 were 1.08B, a 652426.26% increase year-over-year.
- Outlook Therapeutics Inc. long term debt for 2019 were 1.08B, a 652426.26% increase from 2018.
- Outlook Therapeutics Inc. long term debt for 2018 were 164,967, a 19.02% decrease from 2017.
- Outlook Therapeutics Inc. long term debt for 2017 were 203,710, a 92.93% decrease from 2016.
- Outlook Therapeutics Inc. long term debt for 2016 were 2.9M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Outlook Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2019 | $1,076 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $3 |
| 2015 | $3 |
| Outlook Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2019-09-30 | $1,076 |
| 2018-09-30 | $0 |
| 2017-09-30 | $0 |
| 2016-09-30 | $3 |
| 2015-09-30 | $3 |
Outlook Therapeutics Inc. Long Term Debt — FAQ
Outlook Therapeutics Inc. (OTLK) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OTLK's long term debt history?
The chart and table above show Outlook Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.